Michael Vaslamatzis

Tumor to Tumor Metastasis

Constantina Petraki, Michael Vaslamatzis, Theodoros Argyrakos et al. · International Journal of Surgical Pathology · 2003 · 122 citations

Medicine, Oncology, Radiology +15

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours

C.G. Alexopoulos, Michael Vaslamatzis, G Hatzidimitriou · British Journal of Cancer · 1999 · 100 citations · Full text

Medicine, Oncology, Chemotherapy +8

Changes in serum lipids and lipoproteins in cancer patients during chemotherapy

C.G. Alexopoulos, Stavros Pournaras, Michael Vaslamatzis et al. · Cancer Chemotherapy and Pharmacology · 1992 · 70 citations

Life Sciences, Nutritional Sciences, Oncology +13

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

John Souglakos, Ioannis Boukovinas, Stylianos Kakolyris et al. · Annals of Oncology · 2019 · 47 citations · Full text

Medicine, Oncology, Chemotherapy +12

Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma

Constantina Petraki, Alkiviadis Gregorakis, Michael Vaslamatzis et al. · Tumor Biology · 2005 · 41 citations

Medicine, Oncology, Molecular Oncology +15